Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Rho Offers Benefits of Non-Regional Monitoring Strategy vs.Traditional Model

    Apr 23, 2014, 00:00 AM by Michael Croft
    CHAPEL HILL, NC, UNITED STATES - Apr 23, 2014 - Rho, a contract research organization (CRO) focused on bringing new products to market through a full range of product development services, describes four benefits of using a non-regional monitoring strategy for clinical trials versus a traditional regional model
    Full story
  • BaseHealth Seeks New Model for Offering Patients Genetic Health Information

    Apr 22, 2014, 10:55 AM by Michael Croft
    Bio-IT World | This morning, Los Altos-based startup BaseHealth emerged from stealth mode to announce the launch of Genophen, a preventive medicine platform that unites clinical and genetic data to help patients track and manage their risk of developing common chronic diseases.
    Full story
  • Pfizer Rebuffed by AstraZeneca, Regroups

    Apr 22, 2014, 08:00 AM by Michael Croft
    Bloomberg | Talks between Pfizer and AstraZeneca fizzled, but the possibility foretells future big deals, analysts say.
    Full story
  • More Big Pharma Shakeup: Novartis, GSK Trade Assets

    Apr 22, 2014, 08:00 AM by Michael Croft
    REuters | Novartis and GlaxoSmithKline announced this morning that they two big pharma are trading over $20 billion worth of assets in an attempt to strengthen their best businesses
    Full story
  • Genedata at Bio-IT World Announces tranSMART Integration with Genedata Analyst

    Apr 22, 2014, 00:00 AM by Michael Croft
    BASEL, SWITZERLAND - Apr 22, 2014 - Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced it will showcase the integration of Full story
  • QUEEN’S AWARD FOR CAMBRIDGE TEXT ANALYTICS SOFTWARE COMPANY LINGUAMATICS

    Apr 22, 2014, 00:00 AM by Michael Croft
    CAMBRIDGE, UK - Apr 22, 2014 - Linguamatics is today celebrating being named as a winner of the Queen's Award for Enterprise - the UK's highest accolade for business success
    Full story
  • RCRI Inc. Announces Principal Advisor, David France

    Apr 22, 2014, 00:00 AM by Michael Croft
    MINNEAPOLIS, MN - Apr 22, 2014 - Regulatory and Clinical Research Institute, Inc. (RCRI) announced that David France has joined RCRI in the role of Principal Advisor
    Full story
  • BioDatomics Receives New Investment, Grant to Drive Growth of NGS Data Analysis Platform

    Apr 22, 2014, 00:00 AM by Michael Croft
    BETHESDA, MD - Apr 22, 2014 - BioDatomics™, a supplier of bioinformatics analysis software and services that improve genomic research productivity, has received a grant from the National Institutes of Health (NIH) and a capital investment from the Maryland Department of Business and Economic Development's (MDBED) Maryland Venture Fund (MVF)
    Full story
  • Flurry of Big Pharma deals ‘makes sense’

    Apr 22, 2014, 00:00 AM by Michael Croft
    , UK - Apr 22, 2014 - Novartis and GlaxoSmithKline have agreed to exchange assets and combine their consumer healthcare units
    Full story
  • To Speed Sequencing, Edico Genome Proposes NGS Processor

    Apr 21, 2014, 07:00 AM by Michael Croft
    Bio-IT World | Of sequencing bottlenecks, the most lamented is the analysis pipeline. Edico Genome is developing the DRAGEN Bio-IT Processor, the world’s first Next Generation Sequencing (NGS) bioinformatics ASIC to speed and smooth that process.
    Full story
  • Remarkable Twin Study Widens View of Down's Syndrome

    Apr 18, 2014, 08:40 AM by Michael Croft
    Bio-IT World News Brief | A large coalition of European and American researchers this week published a new gene expression study of trisomy 21, better known as Down's syndrome, using a novel cellular model of the disorder.
    Full story
  • As Genetics Moves to the Clinic, Pathogenic Variants Still Subject to Doubt and Debate

    Apr 17, 2014, 10:15 AM by Michael Croft
    Bio-IT World | Genetic diagnostics is a growing field with great promise for improving medical care—yet interpreting the results of tests is a painstaking process, and different labs can disagree on which variants contribute to disease. As open science advocates seek to collect together and curate our knowledge of disease-related genes, the reluctance of many clinical labs to share their data continues to hinder progress.
    Full story
  • Thomson Reuters Names 2014 Drugs to Watch

    Apr 17, 2014, 00:00 AM by Michael Croft
    PHILADELPHIA, PA, US - Apr 17, 2014 -   The Intellectual Property & Science business of Thomson Reuters, the world's leading provider of intelligent information for businesses and professionals, released its annual forecast of the leading drugs to watch in 2014, including three potential blockbuster treatments anticipated to attain more than $1 billion in sales through 2019, after entering the marketplace this year
    Full story
  • Titian Software to Preview Latest Version of its Leading Sample Management Software, Mosaic, at BioIT World

    Apr 16, 2014, 00:00 AM by Michael Croft
    LONDON, UNITED KINGDOM - Apr 16, 2014 - Titian Software (www.titian.co.uk) has announced that it will preview Mosaic 6.0, the latest and most advanced version of its established sample management software, at BioIT World in Boston, MA (29 April – 1 May 2014), booth #353
    Full story
  • Qlucore and Nebion collaboration will benefit researchers

    Apr 16, 2014, 00:00 AM by Michael Croft
    , UK - Apr 16, 2014 - Qlucore and Nebion collaboration will benefit researchers
     
    2014 will see Qlucore and Nebion AG working together to promote their two products Qlucore Omics Explorer and Genevestigator
    Full story
  • Novartis Out of RNAi Research

    Apr 15, 2014, 13:00 PM by Michael Croft
    Forbes | Novartis bows out of RNAi research, the second big pharma to do so.
    Full story
  • Broad Claims Patent on CRISPR Technology

    Apr 15, 2014, 09:35 AM by Michael Croft
    Bio-IT World News Brief | The U.S. Patent and Trademark Office this morning issued the first patent to cover CRISPR-Cas9 gene editing, awarding the Broad Institute a patent for a version of the CRISPR-Cas9 system used to modify the DNA of mammalian cells.
    Full story
  • Certara Acquires Specialty Contract Research Organization Synchrogenix

    Apr 15, 2014, 00:00 AM by Michael Croft
    ST. LOUIS, MO - Apr 15, 2014 - Certara™, the leading technology-enabled drug development and drug safety consultancy, announced today that it has acquired specialty contract research organization (CRO) Synchrogenix Information Strategies Inc
    Full story
  • In Last Sprint to Product Launch, Edico Genome Hints at Massively Accelerated Informatics

    Apr 14, 2014, 13:00 PM by Michael Croft
    U-T San Diego | San Diego-based Edico Genome is working on a chip-based system, the Dragen Wavefront Processor, to perform first-line analysis of genetic information in a fraction of the time required by the fastest current methods.
    Full story
  • NovoPath Debuts Web Portal for Patient Access to Test Result Reports

    Apr 14, 2014, 00:00 AM by Michael Croft
    PRINCETON, NJ - Apr 14, 2014 - NovoPath introduces a customizable web portal to its NovoPath anatomic pathology laboratory information system (APLIS), helping customers efficiently comply with new legislation requiring labs to provide direct patient access to reports
    Full story
  • «
  • 401
  • 402
  • 403
  • 404
  • 405 (current)
  • 406
  • 407
  • 408
  • 409
  • 410
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy